Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women

Technology appraisal guidance
Reference number: TA161
Published: 27 October 2008
Last updated: 07 February 2018

Evaluation report (September 2006)

This evaluation report pertains to both Osteoporosis - primary prevention and Osteoporosis - secondary prevention including strontium ranelate.

Evaluation report (September 2006)

Evaluation report (September 2006)
29 September 2006
()

This page was last updated: 30 March 2010